Minn. lawmaker tackles concerns about proposed 510(k) changes

08/22/2010 | Hill, The

Sen. Al Franken, D-Minn., on Friday held a conference with medical-device companies in Minnesota to discuss their views on the changes proposed by the FDA to the 510(k) process for clearing medical products. Franken is seeking a meeting with FDA Commissioner Margaret Hamburg in September to relay the industry's concerns about the changes in an effort to "continue to foster medical innovation and protect patient safety."

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL